Frontier Biology (688221.SH) announced that the company has received the "Pharmaceutical Supplementary Approval issued by the National Medical Products Administration...
Zhixun Finance APP news, Frontier Biology (688221.SH) announced that the company has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration, approving Aikening (generic name: Aiboweitai) to add "Sichuan Frontier BioPharmaceutical Co., Ltd." (referred to as "Sichuan Frontier") as the active pharmaceutical ingredient supplier; the company's subsidiary Sichuan Frontier received the "Chemical Raw Materials Registration Application Approval Notice" issued by the National Medical Products Administration, approving the domestic production of Aikening chemical raw materials for listing application; at the same time, Sichuan Frontier recently received the "Drug GMP Compliance Inspection Notification" issued by the Sichuan Provincial Medical Products Administration, the Aikening active pharmaceutical ingredient production line passed the drug GMP compliance inspection, complying with the "Drug Production Quality Management Standard (Revised in 2010)" and relevant appendices.
